Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 8/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | BCL9 | O00512 | 1/20 | 0.62 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31329312 | 0.94 | BCL9 (0.57) | KMT2AMAPTLMNAHSD17B10ALDH1A1 | |
| SCHEMBL11023644 | 0.92 | BCL9 (0.70) | KMT2AMAPTLMNAHSD17B10ALDH1A1 | |
| SCHEMBL3498918 | 0.90 | BCL9 (0.53) | KMT2AMAPTLMNAHSD17B10ALDH1A1 | |
| SCHEMBL8631220 | 0.90 | KMT2A (0.76) | KMT2AMAPTLMNAHSD17B10ALDH1A1 | |
| SCHEMBL7500294 | 0.89 | KMT2A (0.58) | KMT2AMAPTLMNAHSD17B10ALDH1A1 | |
| SCHEMBL6836918 | 0.86 | BCL9 (0.64) | KMT2AMAPTLMNAHSD17B10ALDH1A1 | |
| SCHEMBL13557799 | 0.86 | KMT2A (0.64) | KMT2AMAPTLMNAHSD17B10ALDH1A1 | |
| SCHEMBL14984017 | 0.86 | KMT2A (0.64) | KMT2AMAPTLMNAHSD17B10ALDH1A1 | |
| Butane SCHEMBL2851843 | 0.85 | KMT2A (0.59) | KMT2AMAPTLMNAHSD17B10ALDH1A1 | |
| SCHEMBL28611141 | 0.85 | PDGFRB (0.52) | KMT2AMAPTLMNAHSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117700479-A | Targeted prostate specific membrane antigen inhibitor, radioactive marker, preparation method and application thereof | 原子高科股份有限公司 | 2024-03-15 | — | — | CN | claimed |
| US-20220112451-A1 | BOURBON REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. | 2022-04-14 | — | — | US | claimed |
| US-20220010248-A1 | SCOTCH REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. | 2022-01-13 | — | — | US | claimed |
| CN-113825409-A | Whiskey imitation made from individual components | 艾娃食品实验室有限公司 | 2021-12-21 | — | — | CN | claimed |
| US-20210340474-A1 | WHISKEY REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. | 2021-11-04 | — | — | US | claimed |
| EP-3860360-A1 | SCOTCH REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. (US) | 2021-08-11 | — | — | EP | claimed |
| EP-3860359-A1 | WHISKEY REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. (US) | 2021-08-11 | — | — | EP | claimed |
| EP-3755787-A1 | MOSCATO WINE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. (US) | 2020-12-30 | — | — | EP | claimed |
| EP-3755786-A1 | ALCOHOLIC BEVERAGES PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. (US) | 2020-12-30 | — | — | EP | claimed |
| WO-2020072555-A1 | WHISKEY REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. (US) | 2020-04-09 | — | — | WO | claimed |
| WO-2013176897-A2 | COMPOSITION FOR REDUCTION OF TRPA1 AND TRPV1 SENSATIONS | THE PROCTER & GAMBLE COMPANY (US) | 2013-11-28 | — | — | WO | claimed |
| EP-2621462-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | The Procter and Gamble Company (US) | 2013-08-07 | — | — | EP | claimed |
| CN-103153272-A | Compositions comprising derivatives of essential oil compounds and use in personal care products | PROCTER & GAMBLE | 2013-06-12 | — | — | CN | claimed |
| CN-103140209-A | Oral care compositions with improved flavor | PROCTER & GAMBLE | 2013-06-05 | — | — | CN | claimed |
| EP-2595642-A2 | COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS | The Procter and Gamble Company (US) | 2013-05-29 | — | — | EP | claimed |
| WO-2012044728-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-05 | — | — | WO | claimed |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | THE PROCTER & GAMBLE COMPANY | 2012-04-05 | — | — | US | claimed |
| WO-2012012385-A2 | COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-26 | — | — | WO | claimed |
| US-20120014883-A1 | Compositions Comprising Derivatives Of Essential Oil Compounds And Use In Personal Care Products | THE PROCTER & GAMBLE COMPANY | 2012-01-19 | — | — | US | claimed |
| CN-101346073-A | Compositions providing a sensation substantially similar to that provided by menthol | CADBURY ADAMS USA LLC (US) | 2009-01-14 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | TRPA1, TAS2R40, TAS2R30 | KMT2A 1953/4885MAPT 4044/4885LMNA 3584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.